Asian Spectator

Men's Weekly

.

First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT

  • Written by PR Newswire Asia - Asian Spectator
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT

SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has imaged the first patient in its registrational Phase III 6...

Magazine

Female genital cutting: why Southeast Asia should follow Africa’s lead in challenging religious and cultural justifications

Illustration of campaign against Female Genital Mutilation (FGM).Tunatura/ShutterstockFemale genital mutilation or cutting (FGM/C) remains a threat to the rights of women in Southeast Asia, often reli...

Manfaat tempe juga bisa menyehatkan tulang: Mengapa pengakuan dari UNESCO saja tidak cukup?

● Sejumlah negara (seperti Belgia dan Jepang) merekomendasikan warganya memperbanyak konsumsi tempe. ● Tempe punya banyak manfaat kesehatan, termasuk bagi kesehatan tulang.● Pemerint...

Pemberdayaan warga jadi solusi efektif meredam abrasi: Pelajaran dari pesisir Bulukumba

● Indonesia memiliki banyak kawasan pesisir rawan abrasi ekstrem, seperti di Bulukumba, Sulawesi Selatan.● Pemberdayaan masyarakat setempat amat krusial untuk mencegah abrasi.● Pemba...